TABLE 4.
Aspirin monotherapy | 47 (31) | |
| ||
Dual antiplatelet therapy | 37 (24) | |
| ||
Oral anticoagulation | 36 (23) | |
Warfarin | 24 (16) | |
Rivaroxaban | 7 (5) | |
Dabigatran | 5 (3) | |
| ||
No antiplatelet or oral anticoagulation | 29 (19) | |
| ||
Clopidogrel monotherapy | 11 (7) | |
Aggrenox | 1 (0.6) |
Values are n (%).